Works by Yokoyama, Hiroki


Results: 99
    1
    2

    Relationships among Postprandial Plasma Active GLP-1 and GIP Excursions, Skeletal Muscle Mass, and Body Fat Mass in Patients with Type 2 Diabetes Treated with Either Miglitol, Sitagliptin, or Their Combination: A Secondary Analysis of the MASTER Study.

    Published in:
    Journal of Clinical Medicine, 2023, v. 12, n. 9, p. 3104, doi. 10.3390/jcm12093104
    By:
    • Sato, Masahiro;
    • Fujita, Hiroki;
    • Yokoyama, Hiroki;
    • Mikada, Atsushi;
    • Horikawa, Yohei;
    • Takahashi, Yuya;
    • Yamada, Yuichiro;
    • Waki, Hironori;
    • Narita, Takuma
    Publication type:
    Article
    3

    Efficacy of imeglimin treatment versus metformin dose escalation on glycemic control in subjects with type 2 diabetes treated with a dipeptidyl peptidase‐4 inhibitor plus low‐dose metformin: A multicenter, prospective, randomized, open‐label, parallel‐group comparison study (MEGMI study)

    Published in:
    Diabetes, Obesity & Metabolism, 2025, v. 27, n. 3, p. 1466, doi. 10.1111/dom.16150
    By:
    • Takahashi, Akihiro;
    • Nomoto, Hiroshi;
    • Yokoyama, Hiroki;
    • Yokozeki, Kei;
    • Furusawa, Sho;
    • Oe, Yuki;
    • Kameda, Reina;
    • Kawata, Shinichiro;
    • Miyoshi, Arina;
    • Nagai, So;
    • Miya, Aika;
    • Kameda, Hiraku;
    • Nakamura, Akinobu;
    • Atsumi, Tatsuya
    Publication type:
    Article
    4

    Glycaemic control efficacy of switching from dipeptidyl peptidase‐4 inhibitors to oral semaglutide in subjects with type 2 diabetes: A multicentre, prospective, randomized, open‐label, parallel‐group comparison study (SWITCH‐SEMA 2 study)

    Published in:
    Diabetes, Obesity & Metabolism, 2024, v. 26, n. 3, p. 961, doi. 10.1111/dom.15393
    By:
    • Furusawa, Sho;
    • Nomoto, Hiroshi;
    • Yokoyama, Hiroki;
    • Suzuki, Yuka;
    • Tsuzuki, Atsushi;
    • Takahashi, Kiyohiko;
    • Miya, Aika;
    • Kameda, Hiraku;
    • Cho, Kyu Yong;
    • Takeuchi, Jun;
    • Nagai, So;
    • Taneda, Shinji;
    • Kurihara, Yoshio;
    • Nakamura, Akinobu;
    • Atsumi, Tatsuya
    Publication type:
    Article
    5

    Improvement of glycaemic control and treatment satisfaction by switching from liraglutide or dulaglutide to subcutaneous semaglutide in patients with type 2 diabetes: A multicentre, prospective, randomized, open‐label, parallel‐group comparison study (SWITCH‐SEMA 1 study)

    Published in:
    Diabetes, Obesity & Metabolism, 2023, v. 25, n. 6, p. 1503, doi. 10.1111/dom.14998
    By:
    • Takahashi, Yuka;
    • Nomoto, Hiroshi;
    • Yokoyama, Hiroki;
    • Takano, Yoshinari;
    • Nagai, So;
    • Tsuzuki, Atsushi;
    • Cho, Kyu Yong;
    • Miya, Aika;
    • Kameda, Hiraku;
    • Takeuchi, Jun;
    • Taneda, Shinji;
    • Kurihara, Yoshio;
    • Atsumi, Tatsuya;
    • Nakamura, Akinobu;
    • Miyoshi, Hideaki
    Publication type:
    Article
    6

    Favourable effect of the sodium‐glucose co‐transporter‐2 inhibitor canagliflozin plus the dipeptidyl peptidase‐4 inhibitor teneligliptin in combination on glycaemic fluctuation: An open‐label, prospective, randomized, parallel‐group comparison trial (the CALMER study)

    Published in:
    Diabetes, Obesity & Metabolism, 2020, v. 22, n. 3, p. 458, doi. 10.1111/dom.13879
    By:
    • Cho, Kyu Yong;
    • Nomoto, Hiroshi;
    • Nakamura, Akinobu;
    • Kawata, Shinichiro;
    • Sugawara, Hajime;
    • Takeuchi, Jun;
    • Nagai, So;
    • Tsuchida, Kazuhisa;
    • Omori, Kazuno;
    • Yokoyama, Hiroki;
    • Manda, Naoki;
    • Kurihara, Yoshio;
    • Aoki, Shin;
    • Atsumi, Tatsuya;
    • Miyoshi, Hideaki
    Publication type:
    Article
    7
    8
    9
    10
    11

    Pharmacokinetics of intravenous busulfan as condition for hematopoietic stem cell transplantation: comparison between combinations with cyclophosphamide and fludarabine.

    Published in:
    International Journal of Hematology, 2021, v. 113, n. 1, p. 128, doi. 10.1007/s12185-020-02990-y
    By:
    • Kikuchi, Taku;
    • Mori, Takehiko;
    • Ohwada, Chikako;
    • Onoda, Masahiro;
    • Shimizu, Hiroaki;
    • Yokoyama, Hiroki;
    • Onizuka, Makoto;
    • Koda, Yuya;
    • Kato, Jun;
    • Takeda, Yusuke;
    • Hino, Yutaro;
    • Mishina, Tatsuzo;
    • Sakaida, Emiko;
    • Shono, Katsuhiro;
    • Nagao, Yuhei;
    • Yokota, Akira;
    • Matsumoto, Kana;
    • Morita, Kunihiko;
    • Okamoto, Shinichiro
    Publication type:
    Article
    12

    Clinical significance of cancer-related fatigue in multiple myeloma patients.

    Published in:
    2018
    By:
    • Suzuki, Kazuhito;
    • Kobayashi, Nobuyuki;
    • Ogasawara, Yoji;
    • Shimada, Takaki;
    • Yahagi, Yuichi;
    • Sugiyama, Katsuki;
    • Takahara, Shinobu;
    • Saito, Takeshi;
    • Minami, Jiro;
    • Yokoyama, Hiroki;
    • Kamiyama, Yutaro;
    • Katsube, Atsushi;
    • Kondo, Kazuhiro;
    • Yanagisawa, Hiroyuki;
    • Aiba, Keisuke;
    • Yano, Shingo
    Publication type:
    journal article
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22

    Clinical significance of granule-containing myeloma cells in patients with newly diagnosed multiple myeloma.

    Published in:
    Cancer Medicine, 2016, v. 5, n. 11, p. 3051, doi. 10.1002/cam4.875
    By:
    • Suzuki, Kazuhito;
    • Yano, Shingo;
    • Nishiwaki, Kaichi;
    • Sano, Koji;
    • Shimada, Takaki;
    • Yahagi, Yuichi;
    • Ogasawara, Yoji;
    • Sugiyama, Katsuki;
    • Takahara, Shinobu;
    • Saito, Takeshi;
    • Kasama, Kinuyo;
    • Minami, Jiro;
    • Yokoyama, Hiroki;
    • Kamiyama, Yutaro;
    • Katsube, Atsushi;
    • Masuoka, Hidekazu;
    • Katori, Mitsuji;
    • Machishima, Tomohito;
    • Ouchi, Aya;
    • Dobashi, Nobuaki
    Publication type:
    Article
    23

    Impact of COVID‐19 pandemic on behavioral changes and glycemic control and a survey of telemedicine in patients with diabetes: A multicenter retrospective observational study.

    Published in:
    Journal of Diabetes Investigation, 2023, v. 14, n. 8, p. 994, doi. 10.1111/jdi.14027
    By:
    • Bouchi, Ryotaro;
    • Sugiyama, Takehiro;
    • Goto, Atsushi;
    • Ohsugi, Mitsuru;
    • Yoshioka, Narihito;
    • Katagiri, Hideki;
    • Mita, Tomoya;
    • Hirota, Yushi;
    • Ikegami, Hiroshi;
    • Matsuhisa, Munehide;
    • Araki, Eiichi;
    • Yokoyama, Hiroki;
    • Minami, Masae;
    • Yamazaki, Katsuya;
    • Jinnouchi, Hideaki;
    • Ikeda, Hiroki;
    • Fujii, Hitomi;
    • Nogawa, Miyuki;
    • Kaneshige, Masahiro;
    • Miyo, Kengo
    Publication type:
    Article
    24

    The renoprotective effect of once‐weekly GLP‐1 receptor agonist dulaglutide on progression of nephropathy in Japanese patients with type 2 diabetes and moderate to severe chronic kidney disease (JDDM67).

    Published in:
    Journal of Diabetes Investigation, 2022, v. 13, n. 11, p. 1834, doi. 10.1111/jdi.13877
    By:
    • Tsuchida, Ken‐ichi;
    • Taneda, Shinji;
    • Yokota, Isao;
    • Okada, Kazufumi;
    • Kurihara, Yoshio;
    • Yokoyama, Hiroki;
    • Iwamoto, Masahiro;
    • Yamazaki, Katsuya;
    • Ishigaki, Yasushi;
    • Manda, Naoki;
    • Maegawa, Hiroshi
    Publication type:
    Article
    25

    Current status of oral antidiabetic drug prescribing patterns based on the body mass index for Japanese type 2 diabetes mellitus patients and yearly changes in diabetologists' prescribing patterns from 2002 to 2019 (JDDM61).

    Published in:
    Journal of Diabetes Investigation, 2022, v. 13, n. 1, p. 65, doi. 10.1111/jdi.13621
    By:
    • Yagi, Noriharu;
    • Komiya, Ichiro;
    • Arai, Keiko;
    • Oishi, Mariko;
    • Fukumoto, Yoshihide;
    • Shirabe, Shinichirou;
    • Yokoyama, Hiroki;
    • Yamazaki, Katsuya;
    • Sugimoto, Hidekatsu;
    • Maegawa, Hiroshi
    Publication type:
    Article
    26

    Improved time in range and postprandial hyperglycemia with canagliflozin in combination with teneligliptin: Secondary analyses of the CALMER study.

    Published in:
    Journal of Diabetes Investigation, 2021, v. 12, n. 8, p. 1417, doi. 10.1111/jdi.13498
    By:
    • Cho, Kyu Yong;
    • Nomoto, Hiroshi;
    • Nakamura, Akinobu;
    • Kawata, Shinichiro;
    • Sugawara, Hajime;
    • Takeuchi, Jun;
    • Nagai, So;
    • Omori, Kazuno;
    • Tsuchida, Kazuhisa;
    • Miya, Aika;
    • Shigesawa, Ikumi;
    • Tsuchida, Kenichi;
    • Yanagiya, Shingo;
    • Kameda, Hiraku;
    • Yokoyama, Hiroki;
    • Taneda, Shinji;
    • Kurihara, Yoshio;
    • Aoki, Shin;
    • Nishimoto, Naoki;
    • Atsumi, Tatsuya
    Publication type:
    Article
    27

    Impact of endogenous insulin secretion on the improvement of glucose variability in Japanese patients with type 2 diabetes treated with canagliflozin plus teneligliptin.

    Published in:
    Journal of Diabetes Investigation, 2021, v. 12, n. 8, p. 1395, doi. 10.1111/jdi.13479
    By:
    • Miya, Aika;
    • Nakamura, Akinobu;
    • Cho, Kyu Yong;
    • Kawata, Shinichiro;
    • Nomoto, Hiroshi;
    • Nagai, So;
    • Sugawara, Hajime;
    • Taneda, Shinji;
    • Tsuchida, Kazuhisa;
    • Omori, Kazuno;
    • Yokoyama, Hiroki;
    • Takeuchi, Jun;
    • Aoki, Shin;
    • Kurihara, Yoshio;
    • Atsumi, Tatsuya;
    • Miyoshi, Hideaki
    Publication type:
    Article
    28
    29
    30
    31
    32

    Comparison of clinical characteristics in patients with type 2 diabetes among whom different antihyperglycemic agents were prescribed as monotherapy or combination therapy by diabetes specialists.

    Published in:
    Journal of Diabetes Investigation, 2016, v. 7, n. 2, p. 260, doi. 10.1111/jdi.12387
    By:
    • Fujihara, Kazuya;
    • Hanyu, Osamu;
    • Heianza, Yoriko;
    • Suzuki, Akiko;
    • Yamada, Takaho;
    • Yokoyama, Hiroki;
    • Tanaka, Shiro;
    • Yagyu, Hiroaki;
    • Shimano, Hitoshi;
    • Kashiwagi, Atsunori;
    • Yamazaki, Katuya;
    • Kawai, Koichi;
    • Sone, Hirohito
    Publication type:
    Article
    33
    34

    Sex differences in risk factors for end‐stage kidney disease and death in type 2 diabetes: A retrospective cohort study.

    Published in:
    Journal of Diabetes, 2023, v. 15, n. 3, p. 246, doi. 10.1111/1753-0407.13367
    By:
    • Oshima, Megumi;
    • Iwata, Yasunori;
    • Toyama, Tadashi;
    • Kitajima, Shinji;
    • Hara, Akinori;
    • Sakai, Norihiko;
    • Shimizu, Miho;
    • Furuichi, Kengo;
    • Haneda, Masakazu;
    • Babazono, Tetsuya;
    • Yokoyama, Hiroki;
    • Iseki, Kunitoshi;
    • Araki, Shinichi;
    • Ninomiya, Toshiharu;
    • Hara, Shigeko;
    • Suzuki, Yoshiki;
    • Iwano, Masayuki;
    • Kusano, Eiji;
    • Moriya, Tatsumi;
    • Satoh, Hiroaki
    Publication type:
    Article
    35
    36

    Erratum. Alogliptin, a Dipeptidyl Peptidase 4 Inhibitor, Prevents the Progression of Carotid Atherosclerosis in Patients With Type 2 Diabetes: The Study of Preventive Effects of Alogliptin on Diabetic Atherosclerosis (SPEAD-A). Diabetes Care 2016;39:139-148.

    Published in:
    2017
    By:
    • Mita, Tomoya;
    • Katakami, Naoto;
    • Yoshii, Hidenori;
    • Onuma, Tomio;
    • Kaneto, Hideaki;
    • Osonoi, Takeshi;
    • Shiraiwa, Toshihiko;
    • Kosugi, Keisuke;
    • Umayahara, Yutaka;
    • Yamamoto, Tsunehiko;
    • Yokoyama, Hiroki;
    • Kuribayashi, Nobuichi;
    • Jinnouchi, Hideaki;
    • Gosho, Masahiko;
    • Shimomura, Iichiro;
    • Watada, Hirotaka;
    • Collaborators on the Study of Preventive Effects of Alogliptin on Diabetic Atherosclerosis (SPEAD-A) Trial
    Publication type:
    journal article
    37

    Erratum. Sitagliptin Attenuates the Progression of Carotid Intima-Media Thickening in Insulin-Treated Patients With Type 2 Diabetes: The Sitagliptin Preventive Study of Intima-Media Thickness Evaluation (SPIKE). A Randomized Controlled Trial. Diabetes Care 2016;39:455-464.

    Published in:
    2017
    By:
    • Mita, Tomoya;
    • Katakami, Naoto;
    • Shiraiwa, Toshihiko;
    • Yoshii, Hidenori;
    • Onuma, Tomio;
    • Kuribayashi, Nobuichi;
    • Osonoi, Takeshi;
    • Kaneto, Hideaki;
    • Kosugi, Keisuke;
    • Umayahara, Yutaka;
    • Yamamoto, Tsunehiko;
    • Matsumoto, Kazunari;
    • Yokoyama, Hiroki;
    • Tsugawa, Mamiko;
    • Gosho, Masahiko;
    • Shimomura, Iichiro;
    • Watada, Hirotaka;
    • Collaborators on the Sitagliptin Preventive Study of Intima-Media Thickness Evaluation (SPIKE) Trial
    Publication type:
    journal article
    38

    Sitagliptin Attenuates the Progression of Carotid Intima-Media Thickening in Insulin-Treated Patients With Type 2 Diabetes: The Sitagliptin Preventive Study of Intima-Media Thickness Evaluation (SPIKE): A Randomized Controlled Trial.

    Published in:
    2016
    By:
    • Tomoya Mita;
    • Naoto Katakami;
    • Toshihiko Shiraiwa;
    • Hidenori Yoshii;
    • Tomio Onuma;
    • Nobuichi Kuribayashi;
    • Takeshi Osonoi;
    • Hideaki Kaneto;
    • Keisuke Kosugi;
    • Yutaka Umayahara;
    • Tsunehiko Yamamoto;
    • Kazunari Matsumoto;
    • Hiroki Yokoyama;
    • Mamiko Tsugawa;
    • Masahiko Gosho;
    • Iichiro Shimomura;
    • Hirotaka Watada;
    • Mita, Tomoya;
    • Katakami, Naoto;
    • Shiraiwa, Toshihiko
    Publication type:
    journal article
    39

    Alogliptin, a Dipeptidyl Peptidase 4 Inhibitor, Prevents the Progression of Carotid Atherosclerosis in Patients With Type 2 Diabetes: The Study of Preventive Effects of Alogliptin on Diabetic Atherosclerosis (SPEAD-A).

    Published in:
    2016
    By:
    • Tomoya Mita;
    • Naoto Katakami;
    • Hidenori Yoshii;
    • Tomio Onuma;
    • Hideaki Kaneto;
    • Takeshi Osonoi;
    • Toshihiko Shiraiwa;
    • Keisuke Kosugi;
    • Yutaka Umayahara;
    • Tsunehiko Yamamoto;
    • Hiroki Yokoyama;
    • Nobuichi Kuribayashi;
    • Hideaki Jinnouchi;
    • Masahiko Gosho;
    • Iichiro Shimomura;
    • Hirotaka Watada;
    • Mita, Tomoya;
    • Katakami, Naoto;
    • Yoshii, Hidenori;
    • Onuma, Tomio
    Publication type:
    journal article
    40
    41
    42

    Comparative Effects of Direct Renin Inhibitor and Angiotensin Receptor Blocker on Albuminuria in Hypertensive Patients with Type 2 Diabetes. A Randomized Controlled Trial.

    Published in:
    PLoS ONE, 2016, v. 11, n. 12, p. 1, doi. 10.1371/journal.pone.0164936
    By:
    • Uzu, Takashi;
    • Araki, Shin-ichi;
    • Kashiwagi, Atsunori;
    • Haneda, Masakazu;
    • Koya, Daisuke;
    • Yokoyama, Hiroki;
    • Kida, Yasuo;
    • Ikebuchi, Motoyoshi;
    • Nakamura, Takaaki;
    • Nishimura, Masataka;
    • Takahara, Noriko;
    • Obata, Toshiyuki;
    • Omichi, Nobuyuki;
    • Sakamoto, Katsuhiko;
    • Shingu, Ryosuke;
    • Taki, Hideki;
    • Nagai, Yoshio;
    • Tokuda, Hiroaki;
    • Kitada, Munehiro;
    • Misawa, Miwa
    Publication type:
    Article
    43
    44
    45
    46
    47
    48
    49
    50

    Rationale, design, and baseline characteristics of a clinical trial for prevention of atherosclerosis in patients with insulin-treated type 2 diabetes mellitus using DPP-4 inhibitor: the Sitagliptin Preventive study of Intima-media thickness Evaluation (SPIKE)

    Published in:
    Diabetology & Metabolic Syndrome, 2014, v. 6, n. 1, p. 1, doi. 10.1186/1758-5996-6-35
    By:
    • Mita, Tomoya;
    • Katakami, Naoto;
    • Shiraiwa, Toshihiko;
    • Yoshii, Hidenori;
    • Onuma, Tomio;
    • Kuribayashi, Nobuichi;
    • Osonoi, Takeshi;
    • Kaneto, Hideaki;
    • Kosugi, Keisuke;
    • Umayahara, Yutaka;
    • Yamamoto, Tsunehiko;
    • Matsumoto, Kazunari;
    • Yokoyama, Hiroki;
    • Tsugawa, Mamiko;
    • Gosho, Masahiko;
    • Shimomura, Iichiro;
    • Watada, Hirotaka
    Publication type:
    Article